|
|||||
|
|
Results of a 2‐arm,phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation |
|
| Authors: | Sameh Gaballa MD MSc Isabell Ge Riad El Fakih MD Jonathan E. Brammer MD Piyanuch Kongtim MD Ciprian Tomuleasa MD Sa A. Wang MD Dean Lee MD PhD Demetrios Petropoulos MD Kai Cao MS MD Gabriela Rondon MD Julianne Chen BS Aimee Hammerstrom PharmD Lindsey Lombardi PharmD Gheath Alatrash DO PhD Martin Korbling MD Betul Oran MD Partow Kebriaei MD Sairah Ahmed MD Nina Shah MD Katayoun Rezvani MD PhD David Marin MD DM MSc Qaiser Bashir MD Amin Alousi MD Yago Nieto MD PhD Muzaffar Qazilbash MD Chitra Hosing MD Uday Popat MD Elizabeth J. Shpall MD Issa Khouri MD Richard E. Champlin MD Stefan O. Ciurea MD |
| Affiliation: | 1. Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. University Medical Center Freiburg, Freiburg, Germany;3. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas;4. Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas;5. Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| Abstract: | |
| Keywords: | 9/10 matched unrelated donors graft‐versus‐host disease haploidentical transplantation hematologic malignancies post‐transplantation cyclophosphamide |